Churg Strauss syndrome - Successful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment

Clinical and Experimental Rheumatology

Volumn 22, Issue 6 SUPPL., 2004, Pages

  Metzler, Claudia ^a   Hellmich, Bernhard ^a   Gause, Angela ^a   Gross, Wolfgang L ^a   De Groot, Kirsten ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Churg Strauss syndrome; Methotrexate; Relapse; Remission

Indexed keywords

METHOTREXATE; PREDNISOLONE; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEART DISEASE; HUMAN; INFECTION; LEUKOPENIA; LONG TERM CARE; LUNG DISEASE; MAINTENANCE THERAPY; OPEN STUDY; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; TREATMENT OUTCOME; ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; DRUG COMBINATION; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; RESPIRATORY TRACT INFECTION; CLINICAL ASSESSMENT; DISEASE ACTIVITY; PROSPECTIVE STUDY; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; CHURG-STRAUSS SYNDROME; DRUG THERAPY, COMBINATION; FEMALE; HEART DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PREDNISOLONE; RECURRENCE; REMISSION INDUCTION; RESPIRATORY TRACT INFECTIONS;

EID: 15044343279     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. CHURG J, STRAUSS L: Allergic granulomatosis, allergic rhinitis and polyarteritis nodosa. Am J Pathol 1951; 27: 277-301.
2. HELLMICH B, EHLERS S, CSERNOK E, GROSS WL: Update of the pathogenesis of Churg-Strauss syndrome. Clin Exp Rheumatol 2003; 21 (Suppl. 32): S69-S77.
3. GUILLEVIN L, COHEN P, GAYRAUD M, LHOTE F, JARROUSSE B, CASASSUS P: Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999; 78: 26-37.
4. HELLMICH B, GROSS WL: Recent progress in the pharmacotherapy in Churg-Strauss syndrome. Exp Opin Pharmacotherap 2004; 5: 25-35.
5. SCHMITT WH, CSERNOK E, KOBAYASHI S, KLINKENBORG A, REINHOLD-KELLER E, GROSS WL: Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. Arthritis Rheum 1998; 41: 445-52.
6. ARBACH O, GROSS WL, GAUSE A: Treatment of refractory Churg-Strauss- Syndrome (CSS) by TNF-alpha blockade. Immunobiology 2002 Dec; 206: 496-501.
7. WATTS RA, CARRUTHERS DM, SCOTT DG: Epidemiology of systemic vasculitis: changing incidence or definition? Semin Arthritis Rheum 1995 Aug; 25: 28-34.
8. HAUGEBERG G, BIE R, BENDVOLD A, LARSEN AS, JOHNSEN V: Primary vasculitis in a Norwegian community hospital: a retrospective study. Clin Rheumatol 1998; 17: 364-8.
9. LANHAM JG, ELKON KB, PUSEY CD, HUGES GR: Systemic vasculitis with asthma and eosinophilia: A clinical approach to the Churg-Strauss syndrome. Medicine 1984; 63: 65-81
10. SOLANS R, BOSCH JA, PEREZ-BOCANEGRA C et al.: Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology (Oxford) 2001; 40: 763-71.
11. GAYRAUD M, GUILLEVIN L, LE TOUMELIN P et al.: Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001; 44: 666-75.
12. HOFFMAN GS, KERR GS, LEAVITT RY et al.: Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488 -98.
13. EUROPEAN COMMUNITY STUDY GROUP ON CLINICAL TRIALS IN SYSTEMIC VASCULITIS: European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials (ECSYSVASTRIAL). Clin Exp Immunol 1995; 101 (Suppl. 1): 29-34.
14. REINHOLD-KELLER E, BEUGE N, LATZA U et al.: An interdisciplinary approach to the care of patients with Wegener's granulomatosis. Long term outcome in 155 patients. Arthritis Rheum 2000; 43: 1021-32.
15. TALAR-WILLIAMS C, HIJAZI YM, WALTHER MM et al.: Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener's granulomatosis. Ann Intern Med 1996; 124: 477-84.
16. SNELLER MC, HOFFMAN GS, TALAR-WILLIAMS C, KERR GS, HALLAHAN CW, FAUCI AS: An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum 1995; 38: 608-13.
17. DE GROOT K, MÜHLER M, REINHOLD-KELLER E, PAULSEN J, GROSS WL: Induction of remission in Wegener's granulomatosis with low-dose methotrexate. J Rheumatol 1998; 25: 492-5.
18. DE GROOT K, REINHOLD-KELLER E, TATSIS E, PAULSEN J, HELLER M, GROSS WL: Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum 1996; 39: 2052-61.
19. LANGFORD CA: Treatment of ANCA-associated vasculitis. N Engl J Med 2003 Jul 3; 349: 3-4.
20. REINHOLD-KELLER E, FINK CO, HERLYN K, GROSS WL, DE GROOT K: High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate. Arthritis Rheum 2002; 47: 326-32.
21. DE GROOT K, RASMUSSEN N, BACON PA et al.: Randomized trial of cyclophosphamide versus melhotrexate for induction of remission in "non-renal" ANCA-associated vasculitis. Arthritis Rheum 2003, 48 (Suppl.): 660 (1726).
22. JENNETTE JC, FALK RJ, ANDRASSY K et al.: Nomenclature of systemic vasculitides: The proposal of an International Consensus Conference. Arthritis Rheum 1994; 37: 187-92.
23. MASI AT, HUNDER GG, LIE JT et al.: The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angitis). Arthritis Rheum 1990; 33: 1094-100.
24. VAN EDE AE, LAAN RF, ROOD MJ, HUIZINGA TW et al.: Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2001 Jul; 44 1515-24
25. LUQMANI R: Evaluation of vasculitis disease activity in Europe. Eur J Intern Med 2001 Sep; 12: 401-2.
26. DE GROOT K, GROSS WL, HERLYN K, REINHOLD-KELLER E: Development and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol 2001; 55: 31-8.
27. CHAKRAVARTI IM, LAHA RG, ROY J: Handbook of Methods of Applied Statistics, Volume I, John Wiley and Sons, 1967; 392-4.
28. TATSIS E, SCHNABEL A, GROSS WL: Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med 1998; 129: 370-4.